HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Taiji Tsukamoto Selected Research

Equol

9/2016Relationship of serum levels and dietary intake of isoflavone, and the novel bacterium Slackia sp. strain NATTS with the risk of prostate cancer: a case-control study among Japanese men.
1/2014Counts of Slackia sp. strain NATTS in intestinal flora are correlated to serum concentrations of equol both in prostate cancer cases and controls in Japanese men.
1/2013Influence of isoflavone intake and equol-producing intestinal flora on prostate cancer risk.
1/2012Prostate cancer chemoprevention study: an investigative randomized control study using purified isoflavones in men with rising prostate-specific antigen.
2/2004Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents.
8/2003Higher consumption of green tea may enhance equol production.
8/2002Is daidzein non-metabolizer a high risk for prostate cancer? A case-controlled study of serum soybean isoflavone concentration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Taiji Tsukamoto Research Topics

Disease

60Prostatic Neoplasms (Prostate Cancer)
01/2021 - 02/2002
59Neoplasms (Cancer)
12/2020 - 02/2002
35Renal Cell Carcinoma (Grawitz Tumor)
07/2016 - 01/2002
25Urinary Bladder Neoplasms (Bladder Cancer)
12/2020 - 01/2004
20Neoplasm Metastasis (Metastasis)
07/2016 - 01/2004
18Urinary Tract Infections (Urinary Tract Infection)
09/2015 - 08/2002
16Infections
04/2014 - 08/2002
15Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2016 - 06/2002
14Carcinoma (Carcinomatosis)
01/2016 - 03/2006
10Lymphatic Metastasis
07/2016 - 11/2002
9Lower Urinary Tract Symptoms
05/2014 - 11/2006
7Urethritis
02/2013 - 08/2003
6Surgical Wound Infection
05/2013 - 06/2004
5Disease Progression
01/2020 - 07/2006
4Overactive Urinary Bladder (Overactive Bladder)
03/2015 - 01/2010
4Fistula
05/2012 - 01/2002
4Margins of Excision
08/2011 - 01/2008
4Erectile Dysfunction
07/2011 - 05/2004
3Sexually Transmitted Diseases (Sexually Transmitted Disease)
05/2015 - 01/2009
3Neuroendocrine Carcinoma
04/2013 - 01/2004
3Interstitial Cystitis (Interstitial Cystitis, Chronic)
01/2013 - 10/2006
3Ganglion Cysts (Ganglion)
07/2011 - 10/2003
3Residual Neoplasm
01/2011 - 02/2006
3Pyelonephritis
11/2010 - 10/2006
3Underactive Urinary Bladder
05/2010 - 11/2006
3Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
05/2010 - 06/2002
3Testicular Neoplasms (Testicular Cancer)
01/2010 - 12/2004
3Prostatitis
04/2008 - 12/2003
3Bacteriuria
04/2007 - 03/2005
2Anemia
07/2016 - 08/2008
2Communicable Diseases (Infectious Diseases)
09/2015 - 12/2003
2Adenocarcinoma
03/2015 - 08/2011
2Hypogonadism (Hypergonadotropic Hypogonadism)
01/2015 - 11/2008
2Hypertension (High Blood Pressure)
06/2013 - 06/2004

Drug/Important Bio-Agent (IBA)

20Anti-Infective Agents (Microbicides)IBA
10/2006 - 08/2002
17AndrogensIBA
01/2021 - 11/2003
11Hormones (Hormone)IBA
09/2016 - 11/2002
10IsoflavonesIBA
09/2016 - 08/2002
10Prostate-Specific Antigen (Semenogelase)IBA
09/2013 - 08/2004
9Sorafenib (BAY 43-9006)FDA Link
10/2015 - 10/2007
7EquolIBA
09/2016 - 08/2002
7Interferon-alpha (Interferon Alfa)IBA
10/2015 - 08/2006
7CytokinesIBA
02/2014 - 03/2006
7Anti-Bacterial Agents (Antibiotics)IBA
05/2013 - 08/2002
6Tamsulosin (Flomax)FDA LinkGeneric
03/2015 - 11/2005
6Messenger RNA (mRNA)IBA
11/2012 - 10/2003
5Testosterone (Sustanon)FDA Link
05/2017 - 06/2004
5daidzeinIBA
09/2016 - 08/2002
5InterferonsIBA
07/2016 - 12/2008
5naftopidilIBA
01/2016 - 11/2005
5Proteins (Proteins, Gene)FDA Link
01/2013 - 12/2004
5AntigensIBA
12/2009 - 05/2006
4GenisteinIBA
09/2016 - 08/2002
4FluoroquinolonesIBA
05/2015 - 01/2007
4Adenosine Monophosphate (AMP)IBA
04/2014 - 10/2002
4Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2013 - 12/2002
4SurvivinIBA
01/2013 - 05/2006
4Cisplatin (Platino)FDA LinkGeneric
08/2012 - 02/2006
4Interleukin-2 (IL2)IBA
08/2011 - 12/2006
4Dutasteride (Avodart)FDA Link
03/2011 - 04/2009
4Nucleic AcidsIBA
07/2009 - 03/2003
3acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamideFDA Link
06/2018 - 06/2012
3Phosphotransferases (Kinase)IBA
11/2012 - 10/2007
3Histocompatibility Antigens Class IIBA
07/2011 - 04/2007
3Solifenacin SuccinateFDA Link
01/2011 - 01/2010
3HLA Antigens (Human Leukocyte Antigens)IBA
12/2009 - 08/2006
3DNA (Deoxyribonucleic Acid)IBA
01/2009 - 03/2003
3Etoposide (VP 16)FDA LinkGeneric
07/2007 - 02/2006
3Androgen Receptors (Androgen Receptor)IBA
01/2005 - 01/2004
2ORALIT (ORS)IBA
09/2016 - 01/2014
2glyciteinIBA
09/2016 - 01/2014
2C-Reactive ProteinIBA
07/2016 - 02/2010
2Transcription Factors (Transcription Factor)IBA
01/2016 - 06/2013
2Penicillins (Penicillin)FDA Link
05/2015 - 08/2005
2Cephalosporins (Cephalosporin Antibiotics)IBA
05/2015 - 08/2005
2Levofloxacin (Levaquin)FDA Link
04/2014 - 06/2011
2Immunoglobulin G (IgG)IBA
08/2013 - 08/2007

Therapy/Procedure

43Therapeutics
01/2021 - 10/2002
23Cystectomy
12/2020 - 01/2004
17Drug Therapy (Chemotherapy)
09/2015 - 03/2005
15Prostatectomy (Retropubic Prostatectomy)
08/2015 - 01/2002
11Castration
01/2020 - 06/2004
11Lymph Node Excision (Lymph Node Dissection)
04/2014 - 11/2002
10Nephrectomy
12/2013 - 01/2002
9Immunotherapy
04/2013 - 05/2006
6Neoadjuvant Therapy
12/2020 - 01/2007
6Operative Surgical Procedures
08/2015 - 08/2002
5Urinary Diversion (Ileal Conduit)
10/2013 - 10/2004
5Aftercare (After-Treatment)
01/2011 - 03/2003
4Radiotherapy
01/2021 - 05/2004
4Intravesical Administration
01/2013 - 08/2006
4Transurethral Resection of Prostate (TURP)
05/2010 - 02/2002
3Nephroureterectomy
01/2013 - 08/2007
3Adrenalectomy
07/2012 - 09/2004
3Conservative Treatment
08/2011 - 01/2002
3Indwelling Catheters (Indwelling Catheter)
04/2007 - 08/2002
2Molecular Targeted Therapy
07/2016 - 06/2013
2Metastasectomy
04/2014 - 06/2013
2Renal Dialysis (Hemodialysis)
12/2013 - 03/2008
2Chemoprevention
07/2013 - 01/2012